Abdul Razaq Khan, Taj Muhammad, Aden Razaq


Background: Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. Dyslipidemia was highly prevalent in all the geopolitical zones with the consistent pattern being low HDL-Cholesterol and high LDL-Cholesterol. The prevalence of dyslipidemia ranged from 60% among apparently healthy to 89% among diabetic. To determine Frequency of dyslipidemia in newly-detected type-2 diabetics.
Material & Methods: This cross sectional descriptive study was conducted at department to general Medicine, Khalifa Gul Nawaz Teaching Hospital, Bannu over 189 patients of type-2 diabetics from January 2017 to November 2017 lipid profile was carry out, once the patients were diagnosed. To find out dyslipidemia.
Results: Out of 189 patients, 123 were males and 66 females with age range of 35-80 years (Means 57.61 years ±10.25 SD). Over all frequency of dyslipidemia in newly-detected type-2 diabetics (T2DM) were observed in 71.4%
Conclusion: The present study provides evidence to suggest that lipid variables are associated with each other in T2DM patient among the population in this part of the world which aggravates the atherogenic process.


Dyslipidemias; Prevalence; Diabetes mellitus.

Full Text:



Dixit AK, Dey R, Suresh A, Chaudhuri S, Panda AK, Mitra A, et al. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital. J Diabetes Metab Disord13:58. doi:10.1186/2251-6581-13-58

Okafor CI, Fasanmade OA, Oke DA. Pattern of dyslipidaemia among Nigerians with type 2 diabetes mellitus. Niger J Clin Pract 2008;11:25-31.

Ahmad A, Khan AR, Raja ZA, G. M. Measurement of serum cholesterol and triglyceride; Evaluation in patients with diabetes, hypertension and cerebrovascular accidents in South Punjab. Professional 2003;10:92-8.

Abdel-Aal NM, Ahmad AT, Froelicher ES, Batieha AM, Hamza MM, Ajlouni KM. Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan. Saudi Med J 2008 ;29:1423-8.

Mahar PS, Awan MZ, Manzar N, Memon MS. Prevalence of type-II diabetes mellitus and diabetic retinopathy: the Gaddap study. J Coll Physicians Surg Pak ;20:528-32.

Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998 ;21:160-78.

Jisieike-Onuigbo NN, Unuigbe EI, Oguejiofor CO. Dyslipidemias in type 2 diabetes mellitus patients in Nnewi South-East Nigeria. Ann Afr Med 2011;10:285-9.

Jayarama N, Reddy M, Lakshmaiah V. Prevalence and pattern of dyslipidemia in Type 2 diabetes mellitus patients in a rural tertiary care centre, southern India. Glob J Med Public Health 2012;1:24–8.

Vijayaraghavan K. Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health 2010;20;9:144. doi: 10.1186/1476-511X-9-144.

World Health O. World Health Statistics 2015. World Health Organization.

Rayman G, Kilvert A. The crisis in diabetes care in England. BMJ 15;345:e5446.

Park K. Park's Textbook of Preventiv E and Social Medicine. M/s Banarsidas Bhanot; 2005.

Khawaja I, Shakoor Z. Hypertension is a major risk factor for stroke in men and women of all ages. J Pak Institute of Med Sci 1993;4:191-4.

Vohra EA, Ahmed WU, Ali M. Aetiology and prognostic factors of patients admitted for stroke. J Pak Med Assoc 2000;50:234-6.

Khan SN, Vohra EA. Risk factors for stroke: A hospital based study. Pak J Med Sci 2007; 23: 17-22.

SH R, A I. Stroke in Hypertensive Patients. The Professional. 2003;10:125-31.

Mumtaz Ali Marwat, Muhammad Usman, Hussain M. Stroke and its Relationship to Risk Factors. Gomal J Med Sci 2009;7:17-21.

Aly Z, Abbas K, Kazim SF, Taj F, Aziz F, Irfan A, et al. Awareness of stroke risk factors, signs and treatment in a Pakistani population. J Pak Med Assoc 2009;59:495-9.

Taskinen MR, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, et al. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes 1986;35:1268-77.

Eisenberg S, Bilheimer DW, Levy RI, Lindgren FT. On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim Biophys Acta. 1973;326:361-77.

Betteridge DJ. Diabetes, lipoprotein metabolism and atherosclerosis. Br Med Bull. 1989;45:285-311.

Barrett-Connor E, Grundy SM, Holdbrook MJ. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 1982;115:657-63.

Howard BV. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians. Diabetes Care 1993;16:284-91.

Chang CJ, Kao JT, Wu TJ, Lu FH, Tai TY. Serum Lipids and Lipoprotein(a) Concentrations in Chinese NIDDM Patients: Relation to metabolic control. Diabetes Care. 1995;18:1191-4

Varley H, Gowenlock AH, McMurray JR, McLauchlan DM. Varley's Practical Clinical Biochemistry. Heinemann Medical; 1988.

Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009;5:150-9.

Nau DP, Mallya U. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am J Manag Care 2005;11:69-73.

Abbate SL, Brunzell JD. Pathophysiology of hyperlipidemia in diabetes mellitus. J Cardiovasc Pharmacol 1990;16 Suppl 9:S1-7.

Packard C, Nunn A, Hobbs R. High density lipoprotein: guardian of the vascular system? Int J Clin Pract 2002;56:761-71.

Elnasri HA, Ahmed AM. Patterns of lipid changes among type 2 diabetes patients in Sudan. East Mediterr Health J 200814:314-24.


  • There are currently no refbacks.

© 2011 Gomal Journal of Medical Sciences